Search company, investor...
Cannara Biotech company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Reverse Merger | IPO

Total Raised


About Cannara Biotech

Cannara Biotech (CSE:LOVE) operates indoor medical cannabis-cultivation facilties.

Cannara Biotech Headquarters Location

333 Decarie Blvd

Montreal, Quebec, H4N 2L6,


(514) 222-4237

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cannara Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cannara Biotech is included in 1 Expert Collection, including Cannabis.



3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Latest Cannara Biotech News

09:00 EDT Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and V...

Sep 20, 2022

. (CNW Group/Cannara Biotech Inc.) "The BC Liquor Distribution Branch has shown great confidence in our  brands' strong value proposition by listing seven SKUs across Tribal, Nugz, and Orchid CBD. We couldn't be happier to see our flower, pre-roll, and hash concentrates ship to British Columbia retailers and consumers this week, and we thank our dedicated team that has overseen the growth and expansion across three of Canada's largest markets, Ontario, Quebec, and British Columbia, in addition to Saskatchewan," said Zohar Krivorot, Chief Executive Officer. This month, the Company also launched its first live resin vape cartridge, Tribal G Mint, in Ontario. "Tribal Gelato Mint flower has been a consumer favorite in Ontario, and a key genetic to capture market share when we entered the market in November 2021. Our 1-gram G Mint live resin vape cartridge contains only fresh frozen Gelato Mint flower (Breeder: Exotic Genetix) that is grown in our facility, with zero additives, for a true-to-cultivar, full flavor experience on the go. The introduction of Tribal's  G Mint live resin vape cartridge is the latest example of Cannara's goal to provide highly desirable premium cannabis products at affordable prices," commented Nicholas Sosiak, Chief Financial Officer. The Company has also introduced a premium universal 510 vape battery, the Tribal UNI Pro ARK, in collaboration with well-known premium vape manufacturer, Yocan, to provide a superior consumer vaping experience. "Cannara is pleased to have partnered with Yocan to deliver a vape battery that we have the utmost confidence in. Cannara is the exclusive partner for custom Uni Pro 2.0 devices in Canada, and we expect this accessory to be a big hit with our customers as we bring this product across all markets in Canada going forward," concluded Mr. Sosiak. The Tribal UNI Pro ARK will be sold through retailers across Canada and direct to consumer via . About Cannara Biotech Inc. Cannara Biotech Inc. ( TSXV: LOVE ) (OTCQB:LOVFF) (FRA:8CB) is a vertically integrated producer of premium- grade cannabis and cannabis-derivative products for the Québec and Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 125,000kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. For more information, please visit . Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE Cannara Biotech Inc. For further information: Nicholas Sosiak, CPA, CA, Chief Financial Officer, [email protected] ; Zohar Krivorot, President & Chief Executive Officer, [email protected] , About Cannara Biotech Inc. ×

Cannara Biotech Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cannara Biotech Rank

  • When was Cannara Biotech founded?

    Cannara Biotech was founded in 2018.

  • Where is Cannara Biotech's headquarters?

    Cannara Biotech's headquarters is located at 333 Decarie Blvd, Montreal.

  • What is Cannara Biotech's latest funding round?

    Cannara Biotech's latest funding round is Reverse Merger.

  • How much did Cannara Biotech raise?

    Cannara Biotech raised a total of $13.36M.

  • Who are the investors of Cannara Biotech?

    Investors of Cannara Biotech include Cannara Biotech and FSD Pharma.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.